Cargando…
Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791317/ https://www.ncbi.nlm.nih.gov/pubmed/33551212 http://dx.doi.org/10.1016/j.annder.2020.12.001 |
| _version_ | 1783633586952339456 |
|---|---|
| author | Souaid, K. Klejtman, T. Kramkimel, N. Isnard, C. Dupin, N. Aractingi, S. |
| author_facet | Souaid, K. Klejtman, T. Kramkimel, N. Isnard, C. Dupin, N. Aractingi, S. |
| author_sort | Souaid, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7791317 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77913172021-01-08 Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic Souaid, K. Klejtman, T. Kramkimel, N. Isnard, C. Dupin, N. Aractingi, S. Ann Dermatol Venereol Letter to the Editor Elsevier Masson SAS. 2021-06 2021-01-08 /pmc/articles/PMC7791317/ /pubmed/33551212 http://dx.doi.org/10.1016/j.annder.2020.12.001 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Souaid, K. Klejtman, T. Kramkimel, N. Isnard, C. Dupin, N. Aractingi, S. Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title | Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title_full | Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title_fullStr | Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title_full_unstemmed | Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title_short | Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic |
| title_sort | topical steroids and topical tacrolimus appear safe regarding the covid-19 epidemic |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791317/ https://www.ncbi.nlm.nih.gov/pubmed/33551212 http://dx.doi.org/10.1016/j.annder.2020.12.001 |
| work_keys_str_mv | AT souaidk topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic AT klejtmant topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic AT kramkimeln topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic AT isnardc topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic AT dupinn topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic AT aractingis topicalsteroidsandtopicaltacrolimusappearsaferegardingthecovid19epidemic |